tnkase | TNKase® Acute ST Elevation Myocardial Infarction Treatme

Keyword	CPC	PCC	Volume	Score	Length of keyword
tnkase	1.14	0.2	5895	26	6

Keyword	CPC	PCC	Volume	Score
tnkase	1.89	0.5	5362	90
tnkase for stroke	0.89	0.9	9066	12
tnkase vs tpa	1.8	1	1388	31
tnkase package insert	1.47	0.8	338	2
tnkase kit	1.67	0.2	4405	70
tnkase contraindications	1.4	0.5	7158	40
tnkase dosing	0.38	0.2	3257	49
tnkase for mi	0.15	0.5	5527	33
tnkase replacement program	1.22	0.7	2906	38
tnkase administration	1.74	0.8	7057	62
tnkase vs alteplase	1.15	0.4	4455	14
tnkase pronunciation	1.1	0.7	1660	9
tnkase for stroke dosing	0.64	1	8578	16

Search Results related to tnkase on Search Engine

TNKase® Acute ST Elevation Myocardial Infarction Treatment
tnkase.com

https://www.tnkase.com/

WEBThe only lytic delivered as a 5-second IV bolus for the treatment of acute ST elevation myocardial infarction (STEMI), TNKase ® (tenecteplase) enables you to intervene quickly. 1. 5-second administration1. With TNKase, the entire dose is delivered based on patient's weight over a single 5-second bolus—no infusion or second bolus is necessary.

DA: 13 PA: 88 MOZ Rank: 16

TNKase Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/tnkase.html

WEBSep 13, 2023 · What is TNKase? TNKase is a thrombolytic (THROM-bo-LIT-ik) drug, sometimes called a "clot-busting" drug. It helps your body produce a substance that dissolves unwanted blood clots. TNKase is used to prevent death in people who have had a heart attack (acute myocardial infarction).

DA: 7 PA: 27 MOZ Rank: 19

TNK tPA, TNKase (tenecteplase) dosing, indications, interactions
medscape.com

https://reference.medscape.com/drug/tnk-tpa-tnkase-tenecteplase-342291

WEBMedscape - Indication-specific dosing for TNK tPA, TNKase (tenecteplase), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...

DA: 54 PA: 79 MOZ Rank: 54

Tenecteplase - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Tenecteplase

WEBTenecteplase, sold under the trade names TNKase, Metalyse and Elaxim, is an enzyme used as a thrombolytic drug. Tenecteplase is a tissue plasminogen activator (tPA) produced by recombinant DNA technology using an established mammalian cell line (Chinese hamster ovary cells).

DA: 85 PA: 12 MOZ Rank: 16

Tnkase (Tenecteplase): Side Effects, Uses, Dosage ... - RxList
rxlist.com

https://www.rxlist.com/tnkase-drug.htm

WEBApr 13, 2023 · TNKase (tenecteplase) is a tissue plasminogen activator (TPA) used to prevent death from a heart attack (acute myocardial infarction). TNKase works by causing the body to over-produce a substance called plasmin to dissolve unwanted blood clots. What Are Side Effects of Tnkase? Tnkase may cause serious side effects including: …

DA: 30 PA: 38 MOZ Rank: 16

Genentech: TNKase® (tenecteplase) - Information for Patients
gene.com

https://www.gene.com/patients/medicines/tnkase

WEBGet answers to your questions about your TNKase prescription. Find important safety information and patient resources for all of our currently marketed medicines.

DA: 34 PA: 35 MOZ Rank: 65

TNKase: Package Insert / Prescribing Information - Drugs.com
drugs.com

https://www.drugs.com/pro/tnkase.html

WEBFeb 7, 2024 · TNKase package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

DA: 51 PA: 79 MOZ Rank: 6

Is tenecteplase ready to replace alteplase to treat acute …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899685/

WEBOct 19, 2021 · Tenecteplase (TNKase, TNK-tPA or TNK) is a thrombolytic agent derived from the tissue plasminogen activator (tPA). It is a 527-amino acid glycoprotein developed by replacing three amino acids at the T, N and K positions of the glycoprotein structure of tPA under genetic recombinant technology.

DA: 31 PA: 49 MOZ Rank: 94

Review of tenecteplase (TNKase) in the treatment of acute …
tandfonline.com

https://www.tandfonline.com/doi/full/10.2147/vhrm.s3848

WEBFeb 26, 2009 · TNKase is equivalent to front-loaded alteplase in terms of mortality and is the only bolus thrombolytic drug for which this equivalence has been formally demonstrated. TNKase appears more potent than alteplase when symptoms duration lasts …

DA: 36 PA: 42 MOZ Rank: 77

DailyMed - TNKASE- tenecteplase kit
nih.gov

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=739a3c53-caf6-40d6-a6af-84ce733a948b

WEBApr 12, 2023 · TNKase® (tenecteplase) for injection, for intravenous ... TNKase® is indicated to reduce the risk of death associated with acute ST elevation myocardial infarction (STEMI). 2.1 Recommended Dosage - Initiate treatment as soon as possible after the onset of STEMI symptoms.

DA: 91 PA: 14 MOZ Rank: 79